EvoEndo® Single-Use Endoscopy System Commercialization
Visualization, diagnosis, and treatment of the upper digestive tract (esophagus, stomach, duodenal bulb)
Key Facts
About EvoEndo
EvoEndo is pioneering a shift in gastrointestinal diagnostics with its FDA-cleared, single-use, ultra-slim endoscopy system designed for sedation-free procedures. The platform combines a disposable scope with a portable controller and utilizes virtual reality for patient distraction, aiming to reduce anesthesia-related risks, lower costs, and improve patient access and convenience. The company's technology is gaining validation through clinical use, with over 2,200 cases completed, and aligns with evolving clinical guidelines, such as the 2025 ACG recommendations for Eosinophilic Esophagitis (EoE), particularly benefiting pediatric populations. EvoEndo operates as a private, commercial-stage company targeting the substantial endoscopy market with a disruptive device-based solution.
View full company profile